Compile Data Set for Download or QSAR
Report error Found 26 Enz. Inhib. hit(s) with all data for entry = 10602
TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458847(US10759792, Compound I-14 | US11325908, Compound I...)
Affinity DataIC50: 100nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458846(US10759792, Compound I-13 | US11325908, Compound I...)
Affinity DataIC50: 100nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458844(US10759792, Compound I-12 | US11325908, Compound I...)
Affinity DataIC50: 100nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458823(US10759792, Compound 9j | US11325908, Compound 9j)
Affinity DataIC50: 100nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458842(US10759792, Compound I-11 | US11325908, Compound I...)
Affinity DataIC50: 100nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458840(US10759792, Compound I-10 | US11325908, Compound I...)
Affinity DataIC50: 100nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458837(US10759792, Compound I-9 | US11325908, Compound I-...)
Affinity DataIC50: 100nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458833(US10759792, Compound I-7 | US11325908, Compound I-...)
Affinity DataIC50: 100nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458835(US10759792, Compound I-8 | US11325908, Compound I-...)
Affinity DataIC50: 100nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458796(US10759792, Compound I-1 | US11325908, Compound I-...)
Affinity DataIC50: 550nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458822(US10759792, Compound I-4 | US11325908, Compound I-...)
Affinity DataIC50: 550nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458831(US10759792, Compound I-6 | US11325908, Compound I-...)
Affinity DataIC50: 550nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458799(US10759792, Compound 9a | US11325908, Compound 9a)
Affinity DataIC50: 5.50E+3nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458843(US10759792, Compound 8q | US11325908, Compound 8q)
Affinity DataIC50: 5.50E+3nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458836(US10759792, Compound 9n | US11325908, Compound 9n)
Affinity DataIC50: 5.50E+3nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458829(US10759792, Compound I-5 | US11325908, Compound I-...)
Affinity DataIC50: 5.50E+3nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458834(US10759792, Compound 9m | US11325908, Compound 9m)
Affinity DataIC50: 5.50E+4nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458832(US10759792, Compound 9l | US11325908, Compound 9l)
Affinity DataIC50: 5.50E+4nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458838(US10759792, Compound 9o | US11325908, Compound 9o)
Affinity DataIC50: 5.50E+4nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458830(US10759792, Compound 9k | US11325908, Compound 9k)
Affinity DataIC50: 5.50E+4nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM553989(US11325908, Compound 8p)
Affinity DataIC50: 5.50E+4nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458812(US10759792, Compound 9h | US11325908, Compound 9h)
Affinity DataIC50: 5.50E+4nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458811(US10759792, Compound I-3 | US11325908, Compound I-...)
Affinity DataIC50: 5.50E+4nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458845(US10759792, Compound 8r | US11325908, Compound 8r)
Affinity DataIC50: 5.50E+4nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458810(US10759792, Compound 9e | US11325908, Compound 9e)
Affinity DataIC50: 5.50E+4nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent

TargetCalcium/calmodulin-dependent protein kinase type II subunit gamma(Human)
The Johns Hopkins University

US Patent
LigandPNGBDBM458804(US10759792, Compound I-2 | US11325908, Compound I-...)
Affinity DataIC50: 5.50E+4nMAssay Description:The inhibition of CaMKII activity was evaluated using a coupled assay measuring ADP released following ATP hydrolysis and phosphor-transfer to the pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/15/2022
Entry Details
Go to US Patent